CancerWorld article on Side Effects of target treatments: Our CML adherence study is mentioned

2015-03-31 13 10 04-Home - Cancer World - Shaping the future of cancer careThe side effects of targeted drugs are poorly documented, and their impact on patients frequently seriously underestimated and undertreated. A new CancerWorld article covers this important issue. Our CML adherence study and the issue of side effects in CML treatment is covered in detail! Also covered: the Myeloma Patients Europe survey and the GIMEMA CML study on the different perceptions of doctors and patients on side effects. A must read!


Please donate!

Please donate!


Tweet Feed

British report finds room for improvement in standardizing BCR-ABL1 testing for chronic myeloid #leukemia #CML

Retweeted Thursday, 27 April 2017

Want to participate at @EHA_Hematology Congress next June? Apply until 29th April for an #EHA22 fellowship here……

Thursday, 27 April 2017

Looking forward to meet you at the 15th #CML Horizons Conference,Frankfurt,26-28 May. Follow us with #CMLHZ17 +Info……

Wednesday, 26 April 2017